Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, number 226.Obstet Gynecol. 2020; 136: 859-867
- Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226.Obstet Gynecol. 2020; 136: e48-e69
- An ethically justified practical approach to offering, recommending, performing, and referring for induced abortion and feticide.Am J Obstet Gynecol. 2009; 560: e1-e6
- Ethical dimensions of first-trimester fetal aneuploidy screening.Clin Obstet Gynecol. 2014; 57: 226-231
- Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.Am J Obstet Gynecol. 2005; 193: 322-326
- Professional ethics in obstetrics and gynecology.Cambridge University Press, Cambridge and New York2020
- An ethically justified framework for clinical investigation to benefit pregnant and fetal patients.Am J Bioeth. 2011; : 1139-1149
- The professional responsibility model of obstetrical ethics: avoiding the perils of clashing rights.Am J Obstet Gynecol. 2011; 205: 315.e1-315.e5
- The unlimited-rights model of obstetric ethics threatens professionalism.BJOG. 2017; 124: 1144-1147
- Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge.Am J Obstet Gynecol. 2008; 199: 19.e1-19.e4
- A randomized trial of prenatal versus postnatal repair of myelomeningocele.N Engl J Med. 2011; 364: 993-1004
U.S. Department of Health and Human Services. Office for Human Research Protections. 45 CFR 46. Available at: 45-CFR-46.HHS.gov, Accessed January 29, 2021.
- Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons.J Am Coll Surg. 2008; 206: 1204-1209
- Certification process of fetal centers in texas and developing national guidelines.Obstet Gynecol. 2020; 135: 141-147
North American Fetal Therapy Network (NAFTNet). Available at: North American Fetal Therapy Network (NAFTNet) NAFTNet, Accessed January 29, 2021.
- Human molecular genetics and genomics - important advances and exciting possibilities.N Engl J Med. 2021; 384: 1-4
- CRISPR-Cas9 gene editing for sickle cell disease and β-Thalassemia.N Engl J Med. 2021; 384: 252-260
Article info
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
